| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FEDERATED HERMES, INC. | $30.8M | 5.1M | ▼−4.8% Reduced · −259K sh | Q1 2026 | |
| 2 | Vivo Capital, LLC | $26.0M | 4.3M | —Held | Q1 2026 | |
| 3 | JANUS HENDERSON GROUP PLC | $25.9M | 4.3M | ▲477× Added · +4.3M sh | Q1 2026 | |
| 4 | BALYASNY ASSET MANAGEMENT L.P. | $25.7M | 4.3M | ▲New +4.3M sh | Q1 2026 | |
| 5 | Logos Global Management LP | $19.4M | 3.2M | ▼−2.9% Reduced · −96K sh | Q1 2026 | |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | $14.2M | 2.4M | —Held | Q1 2026 | |
| 7 | Foresite Capital Management VI LLC | $12.0M | 2.0M | ▲New +2.0M sh | Q1 2026 | |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | $11.1M | 1.8M | ▲New +1.8M sh | Q1 2026 | |
| 9 | Ally Bridge Group (NY) LLC | $10.0M | 1.7M | —Held | Q1 2026 | |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $8.5M | 1.4M | ▼−50% Reduced · −1.4M sh | Q1 2026 | |
| 11 | Trails Edge Capital Partners, LP | $8.5M | 1.4M | ▲New +1.4M sh | Q1 2026 | |
| 12 | DV Trading LLC | $5.4M | 889K | ▲New +889K sh | Q1 2026 | |
| 13 | ACUTA CAPITAL PARTNERS, LLC | $4.3M | 710K | —Held | Q1 2026 | |
| 14 | MILLENNIUM MANAGEMENT LLC | $4.3M | 708K | ▲+414% Added · +570K sh | Q1 2026 | |
| 15 | BlackRock, Inc. | $3.8M | 625K | ▲+760% Added · +552K sh | Q1 2026 | |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | $2.0M | 339K | ▲+384% Added · +269K sh | Q1 2026 | |
| 17 | VANGUARD FIDUCIARY TRUST CO | $1.6M | 264K | ▲New +264K sh | Q1 2026 | |
| 18 | MARSHALL WACE, LLP | $1.3M | 219K | ▲New +219K sh | Q1 2026 | |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $718K | 119K | ▲New +119K sh | Q1 2026 | |
| 20 | NORTHERN TRUST CORP | $562K | 93K | ▲New +93K sh | Q1 2026 | |
| 21 | RENAISSANCE TECHNOLOGIES LLC | $540K | 90K | ▼−40% Reduced · −60K sh | Q1 2026 | |
| 22 | UBS Group AG | $407K | 68K | ▲37× Added · +66K sh | Q1 2026 | |
| 23 | Y-Intercept (Hong Kong) Ltd | $359K | 65K | ▲New +65K sh | Q2 2026 | |
| 24 | STATE STREET CORP | $340K | 56K | ▲+135% Added · +32K sh | Q1 2026 | |
| 25 | Apella Capital, LLC | $202K | 42K | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| UNITED THERAPEUTICS CORPUTHR | 5 funds | $59.5M |
| CELLDEX THERAPEUTICS INCCLDX | 5 funds | $14.9M |
| NVIDIA CORPNVDA | 4 funds | $1.2B |
| STE STR SPDR PT S&P 500 ETFSPYM | 4 funds | $1.1B |
| APPLE INCAAPL | 4 funds | $1.0B |
| ISHARES CORE S&P 500 ETFIVV | 4 funds | $946.5M |
| STE STR SPDR PT DW EU ETFSPDW | 4 funds | $844.3M |
| MICROSOFT CORPMSFT | 4 funds | $598.8M |
| SS SPDR S&P 500 ETF TRUST-USSPY | 4 funds | $545.6M |
| VANGUARD TOTAL STOCK MKT ETFVTI | 4 funds | $513.7M |
| AMAZON.COM INCAMZN | 4 funds | $489.9M |
| VANGUARD S&P 500 ETFVOO | 4 funds | $460.3M |
Ranked by how many of NERV's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 2, 2023 | Luthringer Remy | CEO, Director | Sell (S) | 4K | $14K |
| May 1, 2023 | Ahlholm Frederick W | SVP, CFO and Secretary | Sell (S) | 4K | $16K |
| May 1, 2023 | Race Geoff | President | Sell (S) | 22K | $85K |
| May 1, 2023 | Luthringer Remy | CEO, Director | Sell (S) | 24K | $91K |
| Dec 1, 2021 | Kupfer David | Director | Sell (S) | 56K | $49K |
| Class | 13F holders | Value held |
|---|---|---|
| NERVthis pageEquity | 38 funds | $219.0M |
| NERVGBPStock | 2 funds | $2K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/NERV/capital-change-brief"
Use Arkolith's capital_change_brief for NERV. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NERV. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.